Gefurulimab
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for Gefurulimab, covering 2024-10-23 to 2026-04-01. Get the full timeline:
Most recent: Clinical Trial Update: PK, PD, Safety, and Efficacy Study of Gefurulimab in Pediatric Patients With AChR+ Generalized Myasthenia Gravis [Phase 3]